专利号:WO-2007002173-A1 优先权日:2005-06-22 标 题:Hiv-1 protease inhibitors, and methods of making and using them 发明人:RANA TARIQ M; ALI AKBAR; CAO HONG; SAI KIRAN KUMAR REDDY GA; ANJUM SAIMA GHAFOOR 权利人:UNIV MASSACHUSETTS; RANA TARIQ M; ALI AKBAR; CAO HONG; SAI KIRAN KUMAR REDDY GA; ANJUM SAIMA GHAFOOR 摘要:One aspect of the invention relates to the design, synthesis and biological activity of novel HIV-1 protease inhibitors incorporating N-phenyloxazolidine-5-carboxamides into the (hydroxyethylamino)sulfonamide scaffold as P2 ligands. For example, the present invention relates to inhibitors with variations at the P2 phenyloxazolidine and the P2' phenylsulfonamide moieties. Remarkably, compounds with an (S)-enantiomer of substituted phenyloxazolidines at P2 show highly potent inhibitory activities against wild-type HIV-1 protease. In certain embodiments, the inhibitors of the invention have Ki values in low picomolar (pM) range. In certain embodiments, the inhibitors of the invention were shown to be active against a variety of multi-drug resistant (MDR) HIV-1 proteases, each representing different paradigm of drug resistance.
专利号:BR-102013002260-B1 优先权日:2013-01-30 标题:Synthesis of new 1,2,3-triazoles, composition, uses and method
专利号:CN-115074399-A 优先权日:2021-03-12 标题 :The key enzyme genes EjCYP716A1/2 and EjCYP716C1/2 of loquat triterpene acid synthesis and their applications
专利号:US-2010093823-A1 优先权日:2008-04-30 标 题 :Steroidal compounds as melanogenesis modifiers and uses thereof 发明人:ORLOW SETH J; KOMATSU LI NI 权利人:ORLOW SETH J; KOMATSU LI NI 摘要:A method for the identification of compounds) that control melanin synthesis (melanogenesis), and the preparation and use of such compounds, and compositions and formulations thereof to modify (e.g., inhibit) melanin production are disclosed. A representative compound of the invention is defined by formula I: n n n n n n n n n n The compounds may be prepared as pharmaceutical and cosmetic compositions, and in one embodiment, may be prepared in combination with each other, and with other melanogenesis inhibiting formulations. The compounds, compositions and formulations of the invention may be used for the prevention and treatment of conditions that are causally related to aberrant melanogenesis activity including, by way of non-limiting example, hyperpigmentation and others.
专利号:CN-115074374-B 优先权日:2021-03-12 标题 :The key enzyme genes MdCYP716A2 and MdCYP716C1 of apple triterpene acid synthesis and their application
专利号:CN-103725743-A 优先权日:2014-01-06 标 题:Biocatalytic synthesis method of corosolic acid
1: Jing Z, Rui W, Ruihua L, Hao Y, Hengtong F. Review of the Biological Activity of Maslinic Acid. Curr Drug Targets. 2021;22(13):1496-1506. doi: 10.2174/1389450122666210308111159. 15:3863-3879. doi: 10.2147/DDDT.S326328. 3: Lau WM, Subramaniam M, Goh HH, Lim YM. Temporal gene expression profiling of maslinic acid-treated Raji cells. Mol Omics. 2021 Apr 19;17(2):252-259. doi: 10.1039/d0mo00168f. 40(12):6869-6877. doi: 10.21873/anticanres.14709.
合成参考文献
参考文献:10.1002/pmic.201000271 摘要:Rufino-Palomares E, Reyes-Zurita FJ, Fuentes-Almagro CA, de la Higuera M, Lupiáñez JA, Peragón J. Proteomics in the liver of gilthead sea bream (Sparus aurata) to elucidate the cellular response induced by the intake of maslinic acid. Proteomics. 2011 Aug;11(16):3312–25. doi: 10.1002/pmic.201000271.